You are here

  • Home
  • Archive
  • Volume 12, Issue 7
  • NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer

 

Online download statistics by month:

Online download statistics by month: July 2024 to November 2025

AbstractFullPdf
Jul 2024359361620
Aug 2024439441234
Sep 2024216218143
Oct 2024236241138
Nov 2024279280169
Dec 2024281286141
Jan 2025224224137
Feb 2025693692183
Mar 2025257257174
Apr 2025276276182
May 2025195196143
Jun 2025156157103
Oct 2025001
Nov 2025001
Total361136292369